Zurich Cantonal Bank
GH icon

Zurich Cantonal Bank’s Guardant Health GH Stock Holding History

Zurich Cantonal Bank’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.68M Buy
51,177
+7,481
+17% +$814K 0.01% 563
2026
Q1 		$4.04M Buy
+43,696
New +$4.39M 0.01% 731
2025
Q4 		– Sell
-34,689
Closed -$3.1M – 2941
2025
Q3 		$2.17M Buy
34,689
+948
+3% +$51.6K 0.01% 882
2025
Q2 		$1.76M Buy
33,741
+612
+2% +$27.3K ﹤0.01% 927
2025
Q1 		$1.41M Buy
33,129
+2,641
+9% +$114K ﹤0.01% 981
2024
Q4 		$931K Buy
30,488
+1,502
+5% +$42.3K ﹤0.01% 1219
2024
Q3 		$665K Buy
28,986
+1,844
+7% +$52.2K ﹤0.01% 1363
2024
Q2 		$784K Buy
27,142
+4,651
+21% +$108K ﹤0.01% 1194
2024
Q1 		$464K Sell
22,491
-57
-0.3% -$1.22K ﹤0.01% 1507
2023
Q4 		$610K Sell
22,548
-993
-4% -$26K ﹤0.01% 1378
2023
Q3 		$698K Buy
23,541
+1,531
+7% +$53.8K ﹤0.01% 1199
2023
Q2 		$788K Buy
22,010
+3,775
+21% +$108K ﹤0.01% 1069
2023
Q1 		$427K Buy
18,235
+1,672
+10% +$47.8K ﹤0.01% 1387
2022
Q4 		$451K Buy
16,563
+2,102
+15% +$96.2K ﹤0.01% 1313
2022
Q3 		$778K Buy
14,461
+935
+7% +$48K ﹤0.01% 943
2022
Q2 		$546K Sell
13,526
-163
-1% -$8.08K ﹤0.01% 1169
2022
Q1 		$907K Sell
13,689
-1,272
-9% -$87K ﹤0.01% 983
2021
Q4 		$1.5M Buy
14,961
+3,469
+30% +$359K 0.01% 834
2021
Q3 		$1.44M Buy
11,492
+400
+4% +$47.5K 0.01% 832
2021
Q2 		$1.38M Buy
11,092
+233
+2% +$31.3K 0.01% 812
2021
Q1 		$1.66M Buy
10,859
+1,967
+22% +$297K 0.01% 745
2020
Q4 		$1.15M Buy
8,892
+2,579
+41% +$297K 0.01% 899
2020
Q3 		$706K Hold
6,313
– – 0.01% 944
2020
Q2 		$512K Buy
6,313
+3,220
+104% +$259K ﹤0.01% 993
2020
Q1 		$215K Buy
3,093
+805
+35% +$61.8K ﹤0.01% 1196
2019
Q4 		$179K Hold
2,288
– – ﹤0.01% 1401
2019
Q3 		$146K Buy
2,288
+1,408
+160% +$124K ﹤0.01% 1411
2019
Q2 		$76K Buy
+880
New +$67.2K ﹤0.01% 1781

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Zurich Cantonal Bank's GH Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Guardant Health (GH) stake by 17% in Q2 2026, buying an estimated $814K and bringing the position to 51,177 shares worth $7.68M. The position accounts for 0.01% of the portfolio, ranked #563.

Zurich Cantonal Bank first reported a position in GH in Q2 2019 and has held it in 28 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Zurich Cantonal Bank held 51,177 shares of Guardant Health worth $7.68M as of Q2 2026.
  • Zurich Cantonal Bank bought 7,481 Guardant Health shares in Q2 2026, an estimated $814K.
  • Guardant Health made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #563 holding.
  • Zurich Cantonal Bank first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.